GF Fund Management’s AbbVie ABBV Stock Holding History

GF Fund Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.1M	Buy	48,257 +510	+1%	+$110K	0.15%	92
2026 Q1	$10.4M	Hold	47,747	–	–	0.17%	89
2025 Q4	$10.9M	Sell	47,747 -901	-2%	-$205K	0.19%	90
2025 Q3	$11.3M	Buy	48,648 +5,709	+13%	+$1.16M	0.2%	90
2025 Q2	$7.97M	Sell	42,939 -321	-0.7%	-$59.7K	0.16%	113
2025 Q1	$9.06M	Hold	43,260	–	–	0.21%	92
2024 Q4	$7.69M	Buy	+43,260	New	+$7.95M	0.17%	103

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GF Fund Management's ABBV Position: Q2 2026 in Review

GF Fund Management increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $110K and bringing the position to 48,257 shares worth $12.1M. The position accounts for 0.15% of the portfolio, ranked #92.

GF Fund Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

GF Fund Management held 48,257 shares of AbbVie worth $12.1M as of Q2 2026.
GF Fund Management bought 510 AbbVie shares in Q2 2026, an estimated $110K.
AbbVie made up 0.15% of GF Fund Management's portfolio in Q2 2026, its #92 holding.
GF Fund Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.